

Other version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428324/
![]() |
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis |
|
Authors | ![]() | |
Published in | PloS one. 2019, vol. 14, no. 3, e0213940 | |
Abstract | Low-molecular-weight heparin (LMWH) is usually recommended for the treatment of cancer-associated thrombosis (CAT) but this treatment requires burdensome daily injections. We did a systematic review to compare the efficacy and safety of direct oral anticoagulants (DOAC), vitamin K antagonists (VKA) and LMWH in patients with CAT. | |
Keywords | Acute Disease — Administration — Oral — Anticoagulants/administration & dosage/adverse effects/therapeutic use — Factor Xa Inhibitors/administration & dosage/adverse effects/therapeutic use — Female — Hemorrhage/etiology — Heparin — Low-Molecular-Weight/administration & dosage/adverse effects/therapeutic use — Humans — Male — Neoplasms/complications — Network Meta-Analysis — Recurrence — Risk Factors — Safety — Secondary Prevention — Venous Thromboembolism/drug therapy/etiology/prevention & control — Vitamin K/antagonists & inhibitors | |
Identifiers | PMID: 30897142 | |
Full text |
![]() ![]() Other version: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428324/ |
|
Structures | ||
Research groups | Epidémiologie clinique et biostatistique (115) Geneva Platelet Group (13) | |
Citation (ISO format) | ROSSEL, Anne et al. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis. In: PLOS ONE, 2019, vol. 14, n° 3, p. e0213940. doi: 10.1371/journal.pone.0213940 https://archive-ouverte.unige.ch/unige:145169 |